Bankbiotech
Latest round
- Angel
Last raised
- Aug 2022
Total raised
- $1.5M
Investors
- 2
About Bankbiotech
Established in 2011 and based in Wuhan, China, Bankbiotech has long been committed to the development of innovative antibody drugs and has built a comprehensive multi-dimensional antibody drug development platform. The company's founder, Rui Gong, has a PhD from Wuhan University, worked in antibody research at the National Institutes of Health, and is a researcher and doctoral supervisor at the Wuhan Institute of Virology, Chinese Academy of Sciences. The company has built a novel nano-antibody technology platform to develop innovative antibody drugs. With the proprietary technology, the company has effectively enhanced the stability and anti-aggregation ability of nano-antibodies and extended the plasma half-life to improve the drug-forming properties of nano-antibody drugs. Currently, Bankbiotech has obtained several nanobody drug candidates against viral infectious diseases. We expect to use 2-3 years to obtain clinical approvals for 2-3 innovative drugs.
Who invested in Bankbiotech
2 investors across 1 round
See all investors in Bankbiotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Aug 30, 2022
Amount
$1.5M
Investors
Questions about Bankbiotech
Who invested in Bankbiotech?
Bankbiotech has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bankbiotech raised?
Bankbiotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Bankbiotech last raise money?
Bankbiotech's most recent round on record is a Angel, in Aug 2022.
What does Bankbiotech do?
Established in 2011 and based in Wuhan, China, Bankbiotech has long been committed to the development of innovative antibody drugs and has built a comprehensive multi-dimensional antibody drug development platform.
Where is Bankbiotech headquartered?
Bankbiotech is headquartered in Wuhan, China.
Which VCs invest in companies like Bankbiotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at Bankbiotech's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Angel
Raising like Bankbiotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.